SNCA and cholangiocarcinoma: It has been reported that the expression of SNCA is affected by epigenetic mechanisms in a variety of tumors, such as cholangiocarcinoma (CHOL) [55], colonic adenocarcinoma (COAD) [13], breast cancer [56], and non-Hodgkin lymphoma (NHL) [13] .